vs
CSW INDUSTRIALS, INC.（CSW）とPrestige Consumer Healthcare Inc.（PBH）の財務データ比較。上の社名をクリックして会社を切り替えられます
Prestige Consumer Healthcare Inc.の直近四半期売上が大きい（$283.4M vs $233.0M、CSW INDUSTRIALS, INC.の約1.2倍）。Prestige Consumer Healthcare Inc.の純利益率が高く（16.5% vs 4.4%、差は12.1%）。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い（20.3% vs -2.4%）。Prestige Consumer Healthcare Inc.の直近四半期フリーキャッシュフローが多い（$75.3M vs $22.7M）。過去8四半期でCSW INDUSTRIALS, INC.の売上複合成長率が高い（5.1% vs 1.2%）
プレステージ・コンシューマー・ヘルスケア社はアメリカの企業で、一般用医薬品のヘルスケア製品および家庭用洗浄製品の販売・流通を手がけています。1996年にMedtech Products社、Prestige Brands International社、Spic and Span社の合併により設立され、本社はニューヨーク州タリータウン、バージニア州リンチバーグに製造工場を構えています。
CSW vs PBH — 直接比較
損益計算書 — Q3 FY2026 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $233.0M | $283.4M |
| 純利益 | $10.3M | $46.7M |
| 粗利率 | 39.7% | 55.5% |
| 営業利益率 | 7.4% | 29.1% |
| 純利益率 | 4.4% | 16.5% |
| 売上前年比 | 20.3% | -2.4% |
| 純利益前年比 | -61.9% | -23.5% |
| EPS（希薄化後） | $0.62 | $0.97 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $233.0M | $283.4M | ||
| Q3 25 | $277.0M | $274.1M | ||
| Q2 25 | $263.6M | $249.5M | ||
| Q1 25 | $230.5M | $296.5M | ||
| Q4 24 | $193.6M | $290.3M | ||
| Q3 24 | $227.9M | $283.8M | ||
| Q2 24 | $226.2M | $267.1M | ||
| Q1 24 | $210.9M | $277.0M |
| Q4 25 | $10.3M | $46.7M | ||
| Q3 25 | $40.7M | $42.2M | ||
| Q2 25 | $40.9M | $47.5M | ||
| Q1 25 | $35.1M | $50.1M | ||
| Q4 24 | $26.9M | $61.0M | ||
| Q3 24 | $36.1M | $54.4M | ||
| Q2 24 | $38.6M | $49.1M | ||
| Q1 24 | $31.8M | $49.5M |
| Q4 25 | 39.7% | 55.5% | ||
| Q3 25 | 43.0% | 55.3% | ||
| Q2 25 | 43.8% | 56.2% | ||
| Q1 25 | 44.2% | 57.3% | ||
| Q4 24 | 41.4% | 55.5% | ||
| Q3 24 | 45.6% | 55.5% | ||
| Q2 24 | 47.5% | 54.7% | ||
| Q1 24 | 44.4% | 54.8% |
| Q4 25 | 7.4% | 29.1% | ||
| Q3 25 | 20.5% | 29.1% | ||
| Q2 25 | 20.8% | 28.8% | ||
| Q1 25 | 19.5% | 29.8% | ||
| Q4 24 | 15.3% | 31.7% | ||
| Q3 24 | 22.6% | 29.7% | ||
| Q2 24 | 24.3% | 27.0% | ||
| Q1 24 | 21.0% | 29.7% |
| Q4 25 | 4.4% | 16.5% | ||
| Q3 25 | 14.7% | 15.4% | ||
| Q2 25 | 15.5% | 19.0% | ||
| Q1 25 | 15.2% | 16.9% | ||
| Q4 24 | 13.9% | 21.0% | ||
| Q3 24 | 15.8% | 19.2% | ||
| Q2 24 | 17.1% | 18.4% | ||
| Q1 24 | 15.1% | 17.9% |
| Q4 25 | $0.62 | $0.97 | ||
| Q3 25 | $2.41 | $0.86 | ||
| Q2 25 | $2.43 | $0.95 | ||
| Q1 25 | $2.05 | $1.00 | ||
| Q4 24 | $1.60 | $1.22 | ||
| Q3 24 | $2.26 | $1.09 | ||
| Q2 24 | $2.47 | $0.98 | ||
| Q1 24 | $2.03 | $0.98 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $62.4M |
| 総負債低いほど良い | — | $1.0B |
| 株主資本純資産 | $1.1B | $1.8B |
| 総資産 | $2.3B | $3.5B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.56× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $40.2M | $62.4M | ||
| Q3 25 | $31.5M | $119.1M | ||
| Q2 25 | $38.0M | $139.5M | ||
| Q1 25 | $225.8M | $97.9M | ||
| Q4 24 | $213.8M | $50.9M | ||
| Q3 24 | $273.2M | $51.5M | ||
| Q2 24 | $18.9M | $34.3M | ||
| Q1 24 | $22.2M | $46.5M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $993.1M | ||
| Q2 25 | — | $992.7M | ||
| Q1 25 | $800.1M | $992.4M | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | $166.0M | $1.1B |
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $1.1B | $1.8B | ||
| Q2 25 | $1.1B | $1.9B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.0B | $1.8B | ||
| Q3 24 | $1.0B | $1.7B | ||
| Q2 24 | $650.2M | $1.7B | ||
| Q1 24 | $615.7M | $1.7B |
| Q4 25 | $2.3B | $3.5B | ||
| Q3 25 | $1.5B | $3.4B | ||
| Q2 25 | $1.5B | $3.4B | ||
| Q1 25 | $1.4B | $3.4B | ||
| Q4 24 | $1.4B | $3.3B | ||
| Q3 24 | $1.4B | $3.3B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.0B | $3.3B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | 0.75× | 0.54× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | 0.27× | 0.68× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $78.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $75.3M |
| FCFマージンFCF / 売上 | 9.8% | 26.6% |
| 設備投資強度設備投資 / 売上 | 2.6% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 1.68× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $267.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $28.9M | $78.3M | ||
| Q3 25 | $61.8M | $57.5M | ||
| Q2 25 | $60.6M | $79.0M | ||
| Q1 25 | $27.3M | $61.8M | ||
| Q4 24 | $11.6M | $65.1M | ||
| Q3 24 | $66.8M | $69.8M | ||
| Q2 24 | $62.7M | $54.8M | ||
| Q1 24 | $22.4M | $66.9M |
| Q4 25 | $22.7M | $75.3M | ||
| Q3 25 | $58.7M | $55.4M | ||
| Q2 25 | $57.7M | $78.2M | ||
| Q1 25 | $22.8M | $58.4M | ||
| Q4 24 | $8.5M | $63.5M | ||
| Q3 24 | $61.3M | $67.8M | ||
| Q2 24 | $59.6M | $53.6M | ||
| Q1 24 | $17.5M | $63.8M |
| Q4 25 | 9.8% | 26.6% | ||
| Q3 25 | 21.2% | 20.2% | ||
| Q2 25 | 21.9% | 31.3% | ||
| Q1 25 | 9.9% | 19.7% | ||
| Q4 24 | 4.4% | 21.9% | ||
| Q3 24 | 26.9% | 23.9% | ||
| Q2 24 | 26.3% | 20.1% | ||
| Q1 24 | 8.3% | 23.0% |
| Q4 25 | 2.6% | 1.1% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | 1.1% | 0.3% | ||
| Q1 25 | 2.0% | 1.2% | ||
| Q4 24 | 1.6% | 0.5% | ||
| Q3 24 | 2.4% | 0.7% | ||
| Q2 24 | 1.4% | 0.4% | ||
| Q1 24 | 2.3% | 1.1% |
| Q4 25 | 2.81× | 1.68× | ||
| Q3 25 | 1.52× | 1.36× | ||
| Q2 25 | 1.48× | 1.66× | ||
| Q1 25 | 0.78× | 1.23× | ||
| Q4 24 | 0.43× | 1.07× | ||
| Q3 24 | 1.85× | 1.28× | ||
| Q2 24 | 1.62× | 1.12× | ||
| Q1 24 | 0.71× | 1.35× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
